COMMUNIQUÉS West-GlobeNewswire

Akcea Initiates Phase 2 Study of AKCEA-ANGPTL3-LRx in Patients with Hypertriglyceridemia, Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (NAFLD)

14/12/2017 - 13:00

CAMBRIDGE, Mass., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious [...]

Published Study Reveals NIAGEN® Nicotinamide Riboside is an Effective NAD Precursor to Protect Cardiac Function in an Animal Model of Heart Failure

14/12/2017 - 12:30

IRVINE, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), a fully integrated, science-based, nutraceutical company devoted to improving the way people age, announced important cardiac research [...]

Kraig Biocraft Laboratories Begins Operations in New Laboratory

14/12/2017 - 12:05

ANN ARBOR, Mich., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company has completed the build [...]

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...

14/12/2017 - 11:31

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financ...

14/12/2017 - 11:31

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financiers Sanofi Société [...]

Norrlandsfonden begär konvertering av utestående konvertibellån

14/12/2017 - 08:30

C-RAD har under perioden 2006 – 2013 ställt ut konvertibla skuldebrev till Norrlandsfonden. Samtliga skuldebrev har en löptid t o m 31 januari 2018 om inte konvertering dessförinnan påkallats av konvertibelägare. C-RAD [...]

Issuance of shares pursuant to the restricted share unit reward plan

14/12/2017 - 08:01

Company announcement, Helsinki, 14 December 2017, at 9 am Issuance of shares pursuant to the restricted share unit reward plan Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or the " Company "), a medical technology [...]

Proteostasis Therapeutics Prices Public Offering of Common Stock

14/12/2017 - 02:31

CAMBRIDGE, Mass., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (Nasdaq: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]

argenx raises approximately $231 million in gross proceeds in an upsized U.S. public offering

14/12/2017 - 01:27

Regulated information - Inside information Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody- [...]

Telix Pharmaceuticals and Memorial Sloan Kettering Cancer Center Announce Renal Cancer Collaboration

13/12/2017 - 23:30

MELBOURNE, Australia and NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“ Telix ”, the “ Company ”), an Australian biopharmaceutical company focused on the development of diagnostic [...]

DiaMedica Therapeutics Announces Non-Brokered Private Placement

13/12/2017 - 22:48

MINNEAPOLIS, Dec. 13, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX-V: DMA ) (OTCQB:DMCAF), announces that, subject to TSX Venture Exchange approval, it is undertaking a non-brokered [...]

Nabriva Therapeutics Added to NASDAQ Biotechnology Index

13/12/2017 - 22:05

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]

Flexion Therapeutics Announces Acquisition of Novel, Non-Opioid Asset for Osteoarthritis of the Knee

13/12/2017 - 22:05

Acquisition complements existing portfolio with an innovative, locally administered therapeutic intended to provide persistent effective concentrations of IL-1Ra in the knee for at least a year New preclinical program [...]

ExactCare Pharmacy Welcomes Terry Rogers as Chief Growth Officer

13/12/2017 - 22:00

CLEVELAND, Dec. 13, 2017 (GLOBE NEWSWIRE) -- ExactCare® Pharmacy has expanded its Executive Leadership Team, welcoming seasoned health care executive Terry Rogers to the newly created role of Chief Growth Officer (CGO [...]

ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until December 21, 2017

13/12/2017 - 22:00

EDISON, N.J., Dec. 13, 2017 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today [...]

AveXis Announces Plan to Initiate Phase 1 Trial in SMA Type 2 Utilizing Intrathecal Delivery of AVXS-101

13/12/2017 - 22:00

– The FDA notified AveXis it may initiate the Phase 1 trial in SMA Type 2 based on a review of data provided by the company; trial to commence immediately – – The trial will evaluate safety, dosing and proof of concept [...]

Emerald Health Announces No Material Change

13/12/2017 - 21:00

VICTORIA, British Columbia, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (the “Company”) is issuing this press release in response to a request by the Investment Industry [...]

RedHawk Initiates Plan to Eliminate Debt

13/12/2017 - 21:00

LAFAYETTE, La., Dec. 13, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today that it has received a favorable order from the Circuit Court of the Twelfth Judicial [...]

Tivity Health and Linkwell Health Recognized for Efforts to Engage Seniors through Digital Platform

13/12/2017 - 20:30

NEW YORK and FRANKLIN, Tenn., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ: TVTY ), the leading provider of fitness and health improvement programs for older adults, and Linkwell Health, the leading [...]